Pneumonia Testing Market : Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2028

 

The tiny air sacs known as alveoli are the main target of pneumonia, a lung infection brought on by bacteria, viruses, or fungi. Streptococcus pneumoniae is the most frequent bacterial variety that causes pneumonia. Fever, chills, cough, fatigue, and shortness of breath are some of the signs of pneumonia. Blood tests, chest X-rays, pulse oximetry, and sputum tests can all be used to identify pneumonia in a patient. Additionally, if the patient is older than 65, additional tests are performed to look for pneumonia. For instance, a pleural fluid culture or a CT scan.

Shortness of breath, fever, chest pain, nausea, and vomiting are some symptoms of pneumonia, a complicated infection affecting the lower respiratory tract. Pneumonia Testing Market causes inflammation by filling the lungs' air sacs, or alveoli, with fluid or pus. It affects people with weakened immune systems and is frequently found in children and the elderly. It is primarily brought on by microorganisms, such as bacteria, viruses, fungi, and parasites. The type of pathogens and the severity of the symptoms determine how to treat pneumonia. When pneumonia is brought on by bacterial infections, antibiotics are administered. To treat pneumonia brought on by fungi, antifungals are prescribed. As many other diseases, including pneumonia, share many of the same clinical symptoms, diagnosing pneumonia can be challenging.

Increased adoption of point-of-care (POC) testing and advancements in the nucleic acid detection field on a global scale are the major factors propelling the growth of the global market of Pneumonia Testing Market. The rise in the elderly population, the explosion in diagnostic advancements for pneumonia, and the prevalence of pneumonia in children around the world all contribute to the market's expansion. Additionally, the Pneumonia Testing Market Opportunity, the presence of sophisticated healthcare infrastructure, the availability of reimbursements, and the existence of significant market participants. However, the traditional method, cultures, is still primarily used to identify pneumonia-causing organisms, which can restrain the market's expansion to some extent throughout the forecast period because it is a labor-intensive process.

Key Players

A few of the major companies active in the market for pneumonia testing are Thermo Fisher Scientific Inc., Abbott Laboratories, F-Hoffmann la Roche Ltd., Hologic Inc., bioMerieux, Becton, Dickenson and Company, Bio-Rad Laboratories Inc., Meridian Biosciences, Quest Diagnostics, and Quidel.